Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Biweekly Gemcitabine and Docetaxel as First Line Treatment for Advanced Disease in Elderly Non-Small Cell Lung Cancer (NSCLC) Patients

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by:
Hospital Arnau de Vilanova
ClinicalTrials.gov Identifier:
NCT00905983
First received: May 19, 2009
Last updated: NA
Last verified: May 2009
History: No changes posted
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: September 2011
  Estimated Primary Completion Date: September 2009 (Final data collection date for primary outcome measure)